Related Experiment Video
Updated: Jan 24, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
MicroRNA-125a regulates proliferation and apoptosis of acute myeloid leukemia through targeting NF-κB pathway
1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China. shandongxuruirong@163.com.
Objective:
To elucidate the influence of microRNA-125a on the biological behaviors of acute myeloid leukemia (AML) cells.
Materials And Methods:
MicroRNA-125a mimic and negative control (NC) were constructed and transfected into AML cell line HL60, respectively. Cell viability of HL60 cells transfected with microRNA-125a mimic or NC was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay. Regulatory effects of microRNA-125a on enzyme activities of B-cell lymphoma-2 (Bcl-2), Bcl-xl, caspase-3, and caspase-9 in HL60 cells were quantified by a spectrophotometry. Changes in apoptosis and invasion of HL60 cells overexpressing microRNA-125a were detected by flow cytometry and transwell assay, respectively. Protein levels of cell cycle genes (cyclin B, cdc-2, mdm-2), pro-apoptotic gene p53 and anti-apoptotic gene Bcl-2 in HL60 cells transfected with microRNA-125a mimic or NC were assessed by Western blot. Finally, the mRNA levels of Bax, caspase-8, nuclear factor-κB (NF-κB), and c-myc in HL60 cells with microRNA-125a overexpression were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR).
Results:
MicroRNA-125a expression remarkably increased by transfection of microRNA-125a mimic into HL60 cells, suggesting its sufficient transfection efficacy. MTT assay revealed an inhibited viability after microRNA-125a overexpression. Transfection of microRNA-125a mimic markedly enhanced enzyme activities of caspase-3 and caspase-9, but reduced activities of Bcl-2 and Bcl-xl in HL60 cells than controls (p<0.05). Moreover, microRNA-125a overexpression elevated apoptotic rate as FCM data indicated. Transwell assay demonstrated a decrease in the invasive rate of HL60 cells overexpressing microRNA-125a. Western blot analyses revealed that cell cycle genes all downregulated by transfection of microRNA-125a mimic in HL60 cells. The protein level of p53 upregulated and Bcl-2 downregulated in HL60 cells overexpressing microRNA-125a (p<0.05). Furthermore, mRNA levels of pro-apoptotic genes Bax and caspase-8 were enhanced after microRNA-125a overexpression, while mRNA levels of NF-κB and c-myc were reduced (p<0.05).
Conclusions:
MicroRNA-125a inhibits proliferative and invasive potentials, arrests the cell cycle in the G2/M phase of AML cells by regulating the NF-κB pathway.
Insights
MicroRNA-125a significantly inhibits acute myeloid leukemia (AML) cell growth and invasion. This microRNA also induces apoptosis and cell cycle arrest by regulating the NF-κB pathway in AML cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- MicroRNAs play crucial roles in regulating gene expression and cellular processes.
- Understanding the role of specific microRNAs in AML is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the functional role of microRNA-125a in the biological behavior of acute myeloid leukemia (AML) cells.
- To elucidate the molecular mechanisms by which microRNA-125a affects AML cell proliferation, apoptosis, invasion, and cell cycle.
- To determine the potential of microRNA-125a as a therapeutic target in AML.
Main Methods:
- Transfection of microRNA-125a mimic into the HL60 AML cell line.
- Assessment of cell viability using MTT assay.
- Quantification of apoptosis and invasion via flow cytometry and Transwell assays, respectively.
- Analysis of protein and mRNA expression levels of key genes involved in cell cycle, apoptosis, and signaling pathways (e.g., Bcl-2, caspase-3, p53, NF-κB) using Western blot and qRT-PCR.
Main Results:
- Overexpression of microRNA-125a significantly inhibited HL60 cell viability and proliferation.
- MicroRNA-125a promoted apoptosis by increasing caspase-3 and caspase-9 activities and upregulating pro-apoptotic genes (Bax, p53, caspase-8).
- MicroRNA-125a reduced the invasive potential of AML cells and arrested the cell cycle in the G2/M phase, partly by downregulating cell cycle genes and the NF-κB pathway.
Conclusions:
- MicroRNA-125a acts as a tumor suppressor in AML by inhibiting cell proliferation and invasion.
- MicroRNA-125a induces apoptosis and G2/M cell cycle arrest in AML cells.
- The regulatory effects of microRNA-125a involve modulation of the NF-κB signaling pathway, highlighting its therapeutic potential in AML treatment.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MicroRNAs
MicroRNAs
Apoptosis
Negative Regulator Molecules
GTPases and their Regulation
Large G-proteins,...

